Skip to main content
. 2019 Jul 24;8(8):1088. doi: 10.3390/jcm8081088

Figure 7.

Figure 7

A 36-year-old patient with glioblastoma showed no FMISO uptake before the bevacizumab treatment (upper row). After the treatment, the patient presented with the enlarged tumor in the bilateral frontal lobe (lower row). The tumor showed high FMISO uptake. This patient was considered a ‘non-responder’.